Dr Jason Johnson

Dr Jason Johnson
MSc, PhD

Senior Research Fellow

Atherosclerosis

Research Floor Level 7,
Queens Building, Bristol Royal Infirmary BS2 8HW
(See a map)

Bot, M, Veldhoven, PV, Jager, Sd, Johnson, JL, Nijstad, N, Santbrink, PV, Westra, M, Hoeven, GVD, Gijbels, M, Muller-Tidow, C, Varga, G, Tietge, U, Kuiper, J, Berkel, TV, Nofer, J, Bot, I & Biessen, E 2013, ‘Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice: Hematopoietic Sgpl1-Deficiency in Atherosclerosis’. PLoS ONE, vol 8., pp. e63360
Alexander, M, Moehle, C, Johnson, J, Yang, Z, Lee, J, Jackson, C & Owens, G 2012, ‘Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice’. The Journal of Clinical Investigation, vol 3;122(1)., pp. 70 - 79